US8497385, 19B.0

ID: ALA3674583

Chembl Id: CHEMBL3674583

PubChem CID: 11274239

Max Phase: Preclinical

Molecular Formula: C41H60O13

Molecular Weight: 760.92

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H](CO)OC(=O)C[C@H](O)CCO[C@H](c3ccccc3)C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O3

Standard InChI:  InChI=1S/C41H60O13/c1-5-6-7-8-12-15-35(44)53-39-29(23-36(45)48-4)22-32-25-33(27-42)51-37(46)24-30(43)17-20-49-34(28-13-10-9-11-14-28)26-31-18-21-50-38(52-31)16-19-40(2,3)41(39,47)54-32/h9-11,13-14,16,19,23,30-34,38-39,42-43,47H,5-8,12,15,17-18,20-22,24-27H2,1-4H3/b19-16+,29-23+/t30-,31+,32+,33-,34+,38+,39+,41-/m1/s1

Standard InChI Key:  RJQUTQDJLQDJKQ-MTGQEHGPSA-N

Associated Targets(non-human)

Prkca Protein kinase C alpha (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 760.92Molecular Weight (Monoisotopic): 760.4034AlogP: 5.15#Rotatable Bonds: 10
Polar Surface Area: 176.51Molecular Species: NEUTRALHBA: 13HBD: 3
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.64CX Basic pKa: CX LogP: 5.18CX LogD: 5.18
Aromatic Rings: 1Heavy Atoms: 54QED Weighted: 0.09Np Likeness Score: 1.34

References

1.  (2013)  Bryostatin analogues, synthetic methods and uses, 

Source

Source(1):